Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Karyopharm Therapeut (KPTI)

Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Karyopharm Therapeut 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 USA

www.karyopharm.com Employees: 325 P: 617-658-0600

Description:

Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other major diseases. It serves the healthcare industry throughout the United States. Karyopharm Therapeutics, Inc. is based in United States.

Key Statistics

Overview:

Market Capitalization, $K 112,615
Enterprise Value, $K 59,725
Shares Outstanding, K 124,684
Annual Sales, $ 146,030 K
Annual Net Income, $ -143,100 K
Last Quarter Sales, $ 42,790 K
Last Quarter Net Income, $ 23,790 K
EBIT, $ -130,950 K
EBITDA, $ -133,700 K
60-Month Beta 0.16
% of Insider Shareholders 4.30%
% of Institutional Shareholders 66.44%
Float, K 119,323
% Float 95.70%
Short Volume Ratio 0.48

Growth:

1-Year Return 4.83%
3-Year Return -89.26%
5-Year Return -93.86%
5-Year Revenue Growth 381.31%
5-Year Earnings Growth 60.19%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 08/06/24
Next Earnings Date 11/05/24 [BMO]
Earnings Per Share ttm -1.18
EPS Growth vs. Prev Qtr 37.50%
EPS Growth vs. Prev Year 31.03%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KPTI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -38.72%
Profit Margin % -97.99%
Debt/Equity -0.71
Price/Sales 0.85
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.06
Interest Coverage -4.99
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar